Search Results 81-90 of 16942 for Cannabis
A cannabis use disorder by DSM-5 criteria in partial remission of less than 3 months will be an exclusion from enrollment. Cannabis use disorders in partial ...
... cannabis products. Also, testing can guide therapy, optimizing medications to achieve the best outcomes. Your health care provider can use test results to ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Celecoxib; Ceritinib; Cetirizine; Chlordiazepoxide. Show More. Using this medicine with any of the following ...
Cannabis; Carbidopa; Carbinoxamine; Carisoprodol; Cetirizine; Chloral Hydrate; Chlorzoxazone; Clobazam; Clonazepam; Codeine; Dantrolene; Daridorexant ...
2025; 12(aRTICLE 2). Ghafouri M, Correa da Costa S, Zare Dehnavi A, Gold MS, Rummans TA. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic ...
We help people with cannabis counseling, so we do a lot of that to help with symptom management, and if patients have indications we can certify them for ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Cariprazine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Carphenazine; Cenobamate; Ceritinib; Cetirizine; Chloral Hydrate. Show More. Other Interactions.
Positive toxicology screen for cannabis and cannabis use disorder by structured clinical interview. Participants who use cannabis for recreational or ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.